James S Hagood MD
Professor, Pediatrics, University of North Carolina at Chapel Hill School of Medicine
Join to View Full Profile
333 S. Columbia St.450 MacNider, CB# 7217Chapel Hill, NC 27599
Phone+1 919-966-1055
Fax+1 919-966-6179
Dr. Hagood is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Alabama Medical CenterFellowship, Pediatric Pulmonology, 1991 - 1994
Vanderbilt University Medical CenterResidency, Pediatrics, 1987 - 1991
University of North Carolina at Chapel Hill School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 2010 - Present
NC State Medical License 2018 - 2025
AL State Medical License 1991 - 2009
American Board of Pediatrics Pediatric Pulmonology
Awards, Honors, & Recognition
- Top Doctors:San Diego Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
Publications & Presentations
PubMed
- Predicting lung aging using scRNA-Seq data.Qi Song, Alex Singh, John E McDonough, Taylor S Adams, Robin Vos
Plos Computational Biology. 2024-12-01 - 12 citationsThe US national registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort.Rebekah J Nevel, Gail H Deutsch, Daniel Craven, Robin Deterding, Martha P Fishman
Pediatric Pulmonology. 2024-09-01 - Contemporary and emerging technologies for research in children's rare and interstitial lung disease.Rongbo Li, Naoyuki Sone, Shimpei Gotoh, Xin Sun, James S Hagood
Pediatric Pulmonology. 2024-09-01
Press Mentions
- $3.5 Million Grant Awarded to UNC Researchers for Childhood Respiratory StudiesOctober 11th, 2021
- Newsworthy from the School of Medicine, Week of September 24 – 30September 29th, 2021
UC San Diego Research Team Awarded Funds to Investigate Stem Cell-Based Therapy for Pulmonary FibrosisJuly 27th, 2018- Join now to see all
Grant Support
- Localizing Therapeutics to Target Lung Myofibroblasts and Reverse FibrosisPROTEOGENOMICS RESEARCH INSTIT/SYS/ MED2024–2028
- Localizing Therapeutics to Target Lung Myofibroblasts and Reverse FibrosisPROTEOGENOMICS RESEARCH INSTIT/SYS/ MED2024–2028
- Regulation Of Fibroblast Phenotype In Lung FibrosisNational Heart, Lung, And Blood Institute2010–2011
- Epigenetic Alterations In IPF Fibroblastic FOCINational Heart, Lung, And Blood Institute2009
- Regulation Of Fibroblast Phenotype In Lung FibrosisNational Heart, Lung, And Blood Institute2007–2009
- Role Of Fibroblast Thy-1 In Pulmonary FibrosisNational Heart, Lung, And Blood Institute2002–2005
- Fibroblast CD 90 Expression In Fibrogenic Skin DisordersNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2000–2002
- Fibroblast CD 90 In Arthritis And Inflammatory DisordersNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2000–2001
- Lung Fibroblast Responses To Fibrin/FibrinogenNational Heart, Lung, And Blood Institute1995–1999
Other Languages
- Spanish
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
